After nearly ten years in the Healthcare Intelligence Business, BioWisdom knows that it’s not just about the data – its about the metadata! Metadata brings data to life, it provides context, it transforms, translates and makes relevant those noisy, digital tomes. Intelligent Metadata helps to maximise the value of your content whether it’s brand new or ancient history. That legacy of expertise, observation, labour and investment. Let BioWisdom help you find it, release it, profit from it!
Latest News
Old Data, New Insight
19TH January 2010 Cambridge, UK – BioWisdom. a provider of specialist medical metadata and Intelligence Solutions for Healthcare, is pleased to announce the publication of an exciting new paper in Chem. Res. Toxicol. Using metadata derived from BioWisdom’s Safety Intelligence Program, Alex Tropsha and colleagues at the University of North Carolina have applied QSAR modelling [...]
BioWisdom Announces Release of Safety Intelligence Program Version 3.0
BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that it has released of Version 3 of its award-winning Safety Intelligence Program.
The Safety Intelligence Program is a unique system in providing comprehensive intelligence around compounds causing adverse effects in tissues, and enables in-depth understanding of mechanistic relationships drug-induced [...]
BioWisdom’s Safety Intelligence Program Win’s ‘Best Practice’ Award for Astrazeneca
20 May 2009, Cambridge, UK – BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces that its Safety Intelligence Program has been awarded a prestigious “Best Practices” award at the recent Bio-IT World Life Sciences Conference and Expo in Boston.
This award recognises the implementation of the Safety Intelligence [...]
Biowisdom Selected by AstraZeneca to Create Custom Vocabulary Assertional Meta-Data in Effort to Improve Drug Safety Assessments
BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that AstraZeneca, one of the world’s leading pharmaceutical companies, has selected them to apply the Sofia platform to generate a rich vocabulary and assertional meta-data from thousands of AstraZeneca-owned toxicology reports.
The project will make accessible the wealth of historical [...]
BioWisdom Launches Version 2 of KnowledgeScan and Secures First Project in Support of Clinical Candidate
24 February 2009, Cambridge, UK – BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today launches version 2 of their KnowledgeScan service.
KnowledgeScan provides comprehensive and independent assessment of a business issue, and version 2 extends to the use of BioWisdom’s powerful intelligence software (SofiaTM, OmniViz©, SRSTM) and its range [...]